Pricing
Login
Home
Charts
Search
Watchlist
Products

Supriya Lifescience Ltd

SUPRIYA
₹620.15-0.78%20 Nov 2026
Reports
Pharma API

Supriya Lifescience Ltd

SUPRIYA
₹620.15
-0.78%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,991Cr
Close
Close Price
₹620.15
Industry
Industry
Pharma API
PE
Price To Earnings
28.18
PS
Price To Sales
5.68
Revenue
Revenue
₹879Cr
Rev Gr TTM
Revenue Growth TTM
23.00%
PAT Gr TTM
PAT Growth TTM
-2.84%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
140158161166186184145200206277190206
Growth YoY
Revenue Growth YoY%
33.211.221.718.632.516.4-9.720.311.250.230.83.2
Expenses
ExpensesCr
991039810112011793127134179142161
Operating Profit
Operating ProfitCr
415663656668527372984745
OPM
OPM%
29.635.138.939.035.536.735.636.434.935.325.022.0
Other Income
Other IncomeCr
322323332332
Interest Expense
Interest ExpenseCr
010010100000
Depreciation
DepreciationCr
445556677999
PBT
PBTCr
405360626364476867924138
Tax
TaxCr
10161516161413181718179
PAT
PATCr
303745464750355050742429
Growth YoY
PAT Growth YoY%
212.9-3.456.693.357.036.4-22.19.36.247.3-30.9-42.0
NPM
NPM%
21.323.427.827.825.227.424.025.224.126.812.714.2
EPS
EPS₹
3.74.65.55.75.86.34.36.36.29.23.03.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
140158161166186184145200206277190206
Growth YoY
Revenue Growth YoY%
33.211.221.718.632.516.4-9.720.311.250.230.83.2
Expenses
ExpensesCr
991039810112011793127134179142161
Operating Profit
Operating ProfitCr
415663656668527372984745
OPM
OPM%
29.635.138.939.035.536.735.636.434.935.325.022.0
Other Income
Other IncomeCr
322323332332
Interest Expense
Interest ExpenseCr
010010100000
Depreciation
DepreciationCr
445556677999
PBT
PBTCr
405360626364476867924138
Tax
TaxCr
10161516161413181718179
PAT
PATCr
303745464750355050742429
Growth YoY
PAT Growth YoY%
212.9-3.456.693.357.036.4-22.19.36.247.3-30.9-42.0
NPM
NPM%
21.323.427.827.825.227.424.025.224.126.812.714.2
EPS
EPS₹
3.74.65.55.75.86.34.36.36.29.23.03.6

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
171184213278312391530461570696828879
Growth
Revenue Growth%
23.87.516.030.512.225.535.5-13.023.722.118.923.0
Expenses
ExpensesCr
150166191213213218316332397436534616
Operating Profit
Operating ProfitCr
2017226598173214129173261294263
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.529.9
Other Income
Other IncomeCr
27981158911101111
Interest Expense
Interest ExpenseCr
1012111074432222
Depreciation
DepreciationCr
455567101216202834
PBT
PBTCr
88145796167207123166248275238
Tax
TaxCr
226182344553447616660
PAT
PATCr
669397312415290119188209177
Growth
PAT Growth%
-30.6-0.654.2351.786.068.522.8-40.832.657.811.3-2.8
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.320.2
EPS
EPS₹
3.93.91.25.410.016.918.911.214.823.426.022.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
171184213278312391530461570696828879
Growth
Revenue Growth%
23.87.516.030.512.225.535.5-13.023.722.118.923.0
Expenses
ExpensesCr
150166191213213218316332397436534616
Operating Profit
Operating ProfitCr
2017226598173214129173261294263
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.529.9
Other Income
Other IncomeCr
27981158911101111
Interest Expense
Interest ExpenseCr
1012111074432222
Depreciation
DepreciationCr
455567101216202834
PBT
PBTCr
88145796167207123166248275238
Tax
TaxCr
226182344553447616660
PAT
PATCr
669397312415290119188209177
Growth
PAT Growth%
-30.6-0.654.2351.786.068.522.8-40.832.657.811.3-2.8
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.320.2
EPS
EPS₹
3.93.91.25.410.016.918.911.214.823.426.022.0
Sales CAGR
1 Year19%
3 Years22%
5 Years16%
TTM23%
EBITDA CAGR
1 Year13%
3 Years32%
5 Years11%
TTM2%
PAT CAGR
1 Year11%
3 Years33%
5 Years11%
TTM-3%
Avg. ROCE
1 Year23%
3 Years23%
5 Years24%
TTM19%
CFO / EBITDA
1 Year63%
3 Years64%
5 Years54%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
151515151515161616161616
Reserves
ReservesCr
263140791342546006837999811,1821,227
Current Liabilities
Current LiabilitiesCr
150144146135155146100967787121130
Non Current Liabilities
Non Current LiabilitiesCr
395145243231192529333849
Total Liabilities
Total LiabilitiesCr
2312412452533364457358209211,1171,3571,422
Current Assets
Current AssetsCr
129115120133196265498465398442532571
Non Current Assets
Non Current AssetsCr
102126126120141180237355523675825851
Total Assets
Total AssetsCr
2312412452533364457358209211,1171,3571,422
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
151515151515161616161616
Reserves
ReservesCr
263140791342546006837999811,1821,227
Current Liabilities
Current LiabilitiesCr
150144146135155146100967787121130
Non Current Liabilities
Non Current LiabilitiesCr
395145243231192529333849
Total Liabilities
Total LiabilitiesCr
2312412452533364457358209211,1171,3571,422
Current Assets
Current AssetsCr
129115120133196265498465398442532571
Non Current Assets
Non Current AssetsCr
102126126120141180237355523675825851
Total Assets
Total AssetsCr
2312412452533364457358209211,1171,3571,422

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14272849117764964113165186
Investing Cash Flow
Investing Cash FlowCr
-33-26-55-25-47-60-124-174-152-176
Financing Cash Flow
Financing Cash FlowCr
21-2-20-50-29-15150-10-22-8-10
Net Cash Flow
Net Cash FlowCr
2-2346215139-70-8340
Free Cash Flow
Free Cash FlowCr
-51823549229-11-44-32234
CFO To PAT
CFO To PAT%
237.2471.5318.0124.0159.161.432.170.895.187.688.8
CFO To EBITDA
CFO To EBITDA%
66.4155.9126.475.5118.643.822.849.465.563.163.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14272849117764964113165186
Investing Cash Flow
Investing Cash FlowCr
-33-26-55-25-47-60-124-174-152-176
Financing Cash Flow
Financing Cash FlowCr
21-2-20-50-29-15150-10-22-8-10
Net Cash Flow
Net Cash FlowCr
2-2346215139-70-8340
Free Cash Flow
Free Cash FlowCr
-51823549229-11-44-32234
CFO To PAT
CFO To PAT%
237.2471.5318.0124.0159.161.432.170.895.187.688.8
CFO To EBITDA
CFO To EBITDA%
66.4155.9126.475.5118.643.822.849.465.563.163.2

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,9671,5352,6705,9044,5484,991
Price To Earnings
Price To Earnings
26.117.122.431.421.828.2
Price To Sales
Price To Sales
7.53.34.78.55.55.7
Price To Book
Price To Book
6.42.23.35.93.84.0
EV To EBITDA
EV To EBITDA
17.610.915.022.415.218.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.826.426.337.547.861.556.950.051.258.956.056.0
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.529.9
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.320.2
ROCE
ROCE%
10.710.714.337.645.250.332.917.520.425.023.019.3
ROE
ROE%
14.012.316.042.049.246.024.712.814.618.917.514.3
ROA
ROA%
2.52.43.615.621.827.720.710.912.916.815.412.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,9671,5352,6705,9044,5484,991
Price To Earnings
Price To Earnings
26.117.122.431.421.828.2
Price To Sales
Price To Sales
7.53.34.78.55.55.7
Price To Book
Price To Book
6.42.23.35.93.84.0
EV To EBITDA
EV To EBITDA
17.610.915.022.415.218.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.826.426.337.547.861.556.950.051.258.956.056.0
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.529.9
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.320.2
ROCE
ROCE%
10.710.714.337.645.250.332.917.520.425.023.019.3
ROE
ROE%
14.012.316.042.049.246.024.712.814.618.917.514.3
ROA
ROA%
2.52.43.615.621.827.720.710.912.916.815.412.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr8,9845,7515,4044,9914,9404,5904,432
Close PriceClose₹990.70960.40184.12620.1590.15352.70473.25
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE34.99134.7026.6128.1826.28213.7637.38
Price To SalesPS4.164.711.965.682.1627.684.56
RevenueRevenueCr2,1611,2212,7518792,286166971
Revenue Growth TTMRev Gr TTM%13.4%20.1%26.8%23.0%30.2%13.0%
PAT Growth TTMPAT Gr TTM%7.1%16.5%75.4%-2.8%89.5%28.3%
Market CapitalizationMkt CapCr8,9845,7515,4044,9914,9404,5904,432
Close PriceClose₹990.70960.40184.12620.1590.15352.70473.25
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE34.99134.7026.6128.1826.28213.7637.38
Price To SalesPS4.164.711.965.682.1627.684.56
RevenueRevenueCr2,1611,2212,7518792,286166971
Revenue Growth TTMRev Gr TTM%13.4%20.1%26.8%23.0%30.2%13.0%
PAT Growth TTMPAT Gr TTM%7.1%16.5%75.4%-2.8%89.5%28.3%